期刊文献+

肌钙蛋白Ⅰ和D-二聚体联合检测诊断急性心肌梗死的价值 被引量:2

Value of combining detections of troponin I and D-dimer in diagnosing acute myocardial infarction
下载PDF
导出
摘要 目的:探讨心脏标志物肌钙蛋白I(CTnI)和D-二聚体(D-DI)联合检测在急性心肌梗死(AMI)诊断中的作用。方法:回顾性分析2010年1月至2011年9月广东省人民医院收治286例急性心源性胸痛患者临床资料,根据病情及入院24 h内的CTnI水平的不同将患者分为2组:A组(急性心肌梗死且CTnI水平≥0.5μg/L,48例),B组(经临床确诊为心绞痛且CTnI水平<0.5μg/L,238例)。比较两组患者D-DI水平的不同。结果:A、B两组患者的血清D-DI水平分别为(333.1±857.98)、(157.0±12.9)μg/L,两组比较,差异有统计学意义(P<0.05)。结论:CTnI和D-DI联合检测更有利于AMI的诊断和预后判断。 Objective:To determine the role of combined detection of cardiac marker troponin 1 (CTnI) and D-dimer (D-DI) in diagnosing acute myocardial infarction (AMI). Methods: A retrospective analysis was performed on the clinical data of 286 patients with acute cardiac chest pain who admitted to Guangdong Provincial People's Hospital between January 2010 and September 2011. The patients were divided into 2 groups according to the severity of their condition and level of CTnI within 24 h from admission: group A ( diagnosed with AMI and CTnI level≥0.5 μg/L, n = 48) and group B (clinically diagnosed with angina and CTnI level 〈 0.5μg/L, n = 238). The difference in D-DI level was compared between the two groups. Results: There was a statistically significant difference in serum level of D-DI between group A ( 333.1±857.98 ) μg/L and group B ( 157.0 ± 12.9)μg/L (P 〈 0.05 ). Conclusion: Combined detection of CTnl and D-dimer provides more clinical benefits in diagnosis and prognosis evaluation of AMI.
出处 《广州医学院学报》 2012年第6期54-55,共2页 Academic Journal of Guangzhou Medical College
关键词 急性心肌梗死 心绞痛 肌钙蛋白 D-二聚体 acute myocardial infarction angina CTnl D-dimer
  • 相关文献

参考文献10

二级参考文献63

共引文献101

同被引文献18

  • 1陈丹,潘世扬,张丽霞,高丽,谢而付,黄珮珺,戎国栋.实时荧光定量PCR在人血液循环DNA检测中的应用[J].中华检验医学杂志,2007,30(10):1162-1163. 被引量:6
  • 2Vang C, Wang V , Zeng Y , H al. Rapid health Iransitiim inCliina, 1990-2010: I'indin^s f'rom the (Global Burden of DiseaseStudy 2010U I. Kan(-eu 2013, 381(9882):1987-2015.
  • 3Kim WJ , Kim RK., Kim A,el al. Response to cardiac- markers inhuman serum analyzed by guided-mode resonan.!e hiuserisor[J].Anal Chen., 2010, 82(23) :9686-9693.
  • 4Leon SA, Shapiro B, Sklaroff DM , et al. Free DNA in the serumof cancer paticnls and the effect of therapy [J]. Cancer Res,1977, 37(3):646-650.
  • 5Zhen^; /, Luo Y, MrMasl^r GK. Sensitive and quanJitativenn'asureirxMH of gene expreftsion djreclly from a ‘small amount oJwhole hlood[J].Clin Chern , 2006, 52(7):1294-1302.
  • 6Suzuki IN, Kamataki A , Y amaki J , et a 1. Chara(*terization ofcirculating DINA in healthy human plasma[J].Clin Ciiim Ada,2008, 387(1-2):55-58.
  • 7Akirav EM, LebasU-hi J , Galvan EM , et al. Deteclion of [3 celldeath in diabetes using differentially methylated Circulating 1)N A「J]. Proc Natl AcmlSci U S A, 2011, 108(47):19018-19023.
  • 8Campello Yurgel V,Ikuta N, Bronciani da Rochu A , et al. Roleof plcisma DNA as a predi(*live maker of fatal outcome followingsevere head injuiy in males [J].J Neurotrauma, 2007, 24(7):1172-1181.
  • 9Jing RR, Wang HM, (^ui M,el al. A senyilive methotl toquantify human cell-free circulating DNA in })Io<hI : relevance lomyocardial infarction screening [J]. Clin liiocheni, 2011 , 44(13):1074-1079.
  • 10Gal S, Kidler C, Lo YM , et al. QuantUatinn of circldaling DNAin the serum of breast cancer patients by real-time PCR [J]. Br JCancer, 2004, 90(6):1211-1215.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部